SCHEMBL7966852

SCHEMBL7966852

CC(C)c1cc(/C=C(\C#N)S(=O)(=O)c2ccc(F)cc2F)cc(C(C)C)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.45
LMNA P02545 2/20 0.43
PKM P14618 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PPME1 Q9Y570 1/20 0.42
KMT2A Q03164 3/20 0.38
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 1/20 0.37
KDR P35968 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
ALPG P10696 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966855 1.00 EGFR (0.45) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7966858 1.00 EGFR (0.45) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7963148 0.85 PKM (0.57) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7963152 0.85 PKM (0.57) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7963145 0.85 PKM (0.57) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7960519 0.85 PTGS1 (0.48) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7960515 0.85 PTGS1 (0.48) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7960518 0.85 PTGS1 (0.48) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7966709 0.83 KMT2A (0.49) EGFRLMNAPKML3MBTL1PPME1
SCHEMBL7966706 0.83 KMT2A (0.49) EGFRLMNAPKML3MBTL1PPME1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed